Table 2.
Cluster 1 | Distinctiveness | Cluster 2 | Distinctiveness | Cluster 3 | Distinctiveness | Cluster 4 | Distinctiveness |
---|---|---|---|---|---|---|---|
GP | .277 | Vaccine | .273 | Cell | .153 | Outbreak | .216 |
Cell | .222 | Ebola | .210 | Infection | .131 | Patient | .186 |
Virus | .201 | Virus | .202 | Level | .102 | Case | .164 |
Glycoprotein | .177 | Challenge | .163 | Response | .099 | Human | .096 |
Ebola | .167 | Protect | .154 | Viral | .098 | Antigen | .093 |
Entry | .130 | Lethal | .143 | Endothelial | .084 | Hemorrhagic | .091 |
Viral | .088 | Infection | .134 | Replication | .079 | Fever | .090 |
Fusion | .086 | Mouse | .122 | Patient | .077 | Assay | .090 |
GP2 | .081 | Antibody | .108 | Study | .076 | Serum | .087 |
Surface | .072 | Animal | .102 | Macrophage | .076 | Antibody | .087 |
Cluster 5 | Distinctiveness | Cluster 6 | Distinctiveness | ||||
VP40 | .406 | Protein | .144 | ||||
Bud | .254 | EBOV | .136 | ||||
Protein | .200 | VP35 | .133 | ||||
Particle | .156 | Gene | .094 | ||||
Motif | .143 | RNA | .093 | ||||
Membrane | .126 | Interferon | .087 | ||||
Assembly | .121 | VP24 | .083 | ||||
Ebola | .116 | IFN | .082 | ||||
Matrix | .106 | Response | .079 | ||||
vlp | .106 | Activation | .078 |